荟萃分析
食品药品监督管理局
医学
视网膜
药物试验
临床试验
药品
眼科
重症监护医学
药理学
内科学
作者
Guanran Zhang,Xin Wen,Yanrong Li,Junran Sun,Huixun Jia,Xiaodong Sun
标识
DOI:10.1016/j.phrs.2024.107335
摘要
Faricimab stands as the inaugural and sole bispecific antibody approved by the US Food and Drug Administration (FDA) for intravitreal injection. Nonetheless, the efficacy and safety of intravitreal faricimab remained uncertain.
科研通智能强力驱动
Strongly Powered by AbleSci AI